2022
DOI: 10.1080/13803395.2022.2128067
|View full text |Cite
|
Sign up to set email alerts
|

Multivariable analysis of the relative utility and additive value of eight embedded performance validity tests for classifying invalid neuropsychological test performance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 53 publications
0
4
0
Order By: Relevance
“…In a cross-validation study, Soble, Sharp, et al (2021) similarly found the RAVLT-FC was an effective EVI, but the optimal cut score varied by the severity of verbal memory impairment: ≤14 (no memory impairment; 82% sensitivity/ 89% specificity); ≤13 (mild memory impairment; 66% sensitivity/93% specificity); ≤11 (severe memory impairment; 37% sensitivity/88% specificity). Most recently, Jennette, Rhoads, et al (2022) examined the RAVLT-ES and RAVLT-FC as part of a battery of eight EVIs and found that RAVLT-FC consistently emerged as a significant predictor of validity status and outperformed most of the other EVIs examined in this study. Collectively, similar to the ES, the existing RAVLT-FC literature supports its utility as an EVI across diverse clinical populations, although slight cut score modifications are necessary with increasing impairment severity.…”
mentioning
confidence: 74%
“…In a cross-validation study, Soble, Sharp, et al (2021) similarly found the RAVLT-FC was an effective EVI, but the optimal cut score varied by the severity of verbal memory impairment: ≤14 (no memory impairment; 82% sensitivity/ 89% specificity); ≤13 (mild memory impairment; 66% sensitivity/93% specificity); ≤11 (severe memory impairment; 37% sensitivity/88% specificity). Most recently, Jennette, Rhoads, et al (2022) examined the RAVLT-ES and RAVLT-FC as part of a battery of eight EVIs and found that RAVLT-FC consistently emerged as a significant predictor of validity status and outperformed most of the other EVIs examined in this study. Collectively, similar to the ES, the existing RAVLT-FC literature supports its utility as an EVI across diverse clinical populations, although slight cut score modifications are necessary with increasing impairment severity.…”
mentioning
confidence: 74%
“…The sample was large and ethnically diverse. Performance validity was controlled, using empirically supported criteria for invalidity (Jennette et al, 2022; Rhoads et al, 2021; Sweet et al, 2021). Symptom validity was also controlled, using manual-specified and independently validated criteria (Bracken & Boatwright, 2005; Leib et al, 2022).…”
Section: Discussionmentioning
confidence: 99%
“…As such, a total of 164 patients were administered the BAARS-IV. Patients were excluded if they (1) demonstrated invalid test performance as defined by failure of two or more of the five performance validity tests (PVTs) administered, consistent with current empirically supported practice standards (see Jennette et al, 2022; Rhoads et al, 2021; Sweet et al, 2021), or (2) produced invalid symptom reporting profiles (see below). Of 164 individuals who completed the BAARS-IV, nine had invalid neuropsychological performance data.…”
Section: Methodsmentioning
confidence: 99%
“…Specifically, referral sources were as follows: Memory Disorders Clinic = 154 (35.0%); General Neurology = 83 (18.9%); Movement Disorders Clinic = 52 (11.8%); Epilepsy Clinic = 43 (9.8%); Multiple Sclerosis = 23 (5.2%); Brain Tumor = 17 (3.9%); Other = 68 (15.5%). Eleven patients were excluded from the analysis due to invalid neuropsychological testing results based on scores below cutoff on two or more (Jennette et al, 2022; Rhoads et al, 2021) performance validity measures (Victoria symptom validity test [VSVT] hard score <18: (Grote et al, 2000; Keary et al, 2013; Test of Memory Malingering Trial 1 <40: Denning, 2012; Reliable Digit Span <6: Schroeder et al, 2012). Demographic characteristics for 440 included patients are displayed in Table 1.…”
Section: Methodsmentioning
confidence: 99%